VOSPIRE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vospire, and when can generic versions of Vospire launch?
Vospire is a drug marketed by Strides Pharma Intl and is included in one NDA.
The generic ingredient in VOSPIRE is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vospire
A generic version of VOSPIRE was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VOSPIRE?
- What are the global sales for VOSPIRE?
- What is Average Wholesale Price for VOSPIRE?
Summary for VOSPIRE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | VOSPIRE at DailyMed |
US Patents and Regulatory Information for VOSPIRE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma Intl | VOSPIRE ER | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 076130-002 | Sep 26, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma Intl | VOSPIRE ER | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 076130-003 | Sep 26, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
